Diabetes Metab J.  2020 Apr;44(2):211-212. 10.4093/dmj.2020.0092.

The Outbreak of COVID-19 and Diabetes in Korea:“We Will Find a Way as We Have Always Done”

Affiliations
  • 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea
  • 2Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea


Cited by  1 articles

Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19
Sang Youl Rhee, Jeongwoo Lee, Hyewon Nam, Dae-Sung Kyoung, Dong Wook Shin, Dae Jung Kim
Diabetes Metab J. 2021;45(2):251-259.    doi: 10.4093/dmj.2020.0206.


Reference

1. COVID-19 National Emergency Response Center. Epidemiology and Case Management Team. Korea Centers for Disease Control and Prevention. Coronavirus disease-19: the first 7,755 cases in the Republic of Korea. Osong Public Health Res Perspect. 2020; 11:85–90. PMID: 32257774.
2. Song JY, Yun JG, Noh JY, Cheong HJ, Kim WJ. COVID-19 in South Korea: challenges of subclinical manifestations. N Engl J Med. 2020; 4. 06. DOI: 10.1056/NEJMc2001801. [Epub].
3. Ha E, Kim N, Moon JS, Lee Y, Choi EY. Acute hyperglycemic crises with coronavirus disease-19 (COVID-19): case series. Diabetes Metab J. 2020; 44:349–353.
4. Keesara S, Jonas A, Schulman K. COVID-19 and health care's digital revolution. N Engl J Med. 2020; 4. 02. DOI: 10.1056/NEJMp2005835. [Epub].
Article
Full Text Links
  • DMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr